Please assess the completion status of the following clinical trial:

Trial Title: Stress Ulcer Prophylaxis of Intravenous Esomeprazole in Chinese Seriously Ill Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Critically ill patients~2. Requirement for mechanical ventilation~3. At least one major risk factor for stress ulcer related bleeding~Exclusion Criteria:~1. History of gastric or oesophageal surgery~2. Evidence of active GI bleeding~3. Advanced renal disease~4. Treatment with any Proton Pump Inhibitors

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Esomeprazole active treatment (Type: EXPERIMENTAL): iv esomeprazole 30 min intermittent infusions given for maximum 14 days
- Cimetidine active treatment (Type: ACTIVE_COMPARATOR): iv cimetidine 30 min bolus infusion followed by iv cimetidine continuous infusion given for maximum 14 days

Based on this trial design, predict the completion outcome and termination type (if applicable).